North India · Hospital Chain · Pre-IPO
Park Medi World Limited
The second-largest private hospital chain in North India — 13 NABH-accredited hospitals, 3,000 beds, and a track record of profitable acquisitions delivering high-quality affordable healthcare across Haryana, Delhi, Punjab, and Rajasthan.
Raising $300M Pre-IPO
13 Hospitals · 3,000 Beds
$1.5B Valuation
Wellness for all.
Scale with conviction.

Park Medi World operates the largest private hospital chain in Haryana and the second-largest in all of North India — delivering super-specialty care at industry-leading profitability while scaling through a proven cluster-based acquisition model. The company has filed its DRHP with SEBI for an initial public offer.

Filed: DRHP · March 28, 2025
Investment Overview
Pre-IPO Raise$300,000,000
Equity on Offer20%
Valuation$1.5 Billion
Basis10× FY24 revenue
Projected IPO Upside2–3× in near term
FY24 RevenueINR 12,311 mn
FY24 EBITDA Margin25%
FY24 ROE18%
01
Executive Summary
The Opportunity

Park Medi World Limited — operator of the Park Hospitals brand — runs the second-largest private hospital chain in North India by bed capacity and the largest in Haryana. The network comprises 13 NABH-accredited hospitals (7 of which are NABL-accredited multi-super-specialty hospitals), 3,000 beds (including 805 ICU beds), 891 doctors and 1,912 nurses, and delivers 30+ super-specialty and specialty services across Haryana, Delhi, Punjab, and Rajasthan.

The company is raising $300M for 20% equity at a $1.5B valuation in a pre-IPO round. This values Park Medi World at approximately 10× FY24 top-line revenue — a material discount to Indian hospital-sector comparables which trade at 20–30× revenue (a recent South India hospital transacted at 30×). After the pre-IPO close, Park will proceed to a public listing, which management projects will double the equity valuation, giving pre-IPO investors a conservative 2–3× MOIC in a short horizon.

The investment thesis rests on three pillars: (1) scale in an underserved region — North India has bed density well below the National Health Policy threshold of 20 beds / 10,000 people, with Haryana at 13.5 and UP at 12–13; (2) proven M&A integration — 7 hospitals acquired and integrated, contributing ~41% of FY24 EBITDA at an aggregate consideration of INR 5.2bn; and (3) best-in-class profitability — Park's 25% EBITDA margin tops all listed Indian hospital peers (Fortis, Medanta, Max, Narayana, KIMS, Jupiter).

02
Performance Metrics
Scale · Efficiency · Profitability · Capital Deployment
Value Creation Pathway
Current Scale
13 Hospitals
North India network
Pre-IPO Raise
$300M
20% equity
Valuation
$1.5B
Pre-money
5-Year Growth
Scale-up
Financial trajectory
IPO Exit
Target
Public markets
FY24 Revenue
INR 12,311 mn
H1 FY25: INR 6,915 mn
FY24 EBITDA Margin
25%
H1 FY25: 27% · highest among listed peers
FY24 ROCE / ROE
16% / 18%
3,000 beds · 805 ICU · 63 OTs
Patient Volume FY24
~571K
Inpatient + Outpatient
5-Year Financial Trajectory
MetricFY22FY23FY24H1 FY25
Revenue (INR mn)10,84412,54612,3116,915
EBITDA (INR mn)3,4373,9033,1031,896
EBITDA Margin32%31%25%27%
PAT (INR mn)1,9942,2821,5201,129
PAT Margin18%18%12%16%
Bed Capacity2,2502,5502,9003,000
ARPOB (INR/day)24,40724,57524,91925,674
ROCE29%27%16%9.6%*
ROE42%36%18%11.4%*

*H1 FY25 figures non-annualised

03
Projects
Hospital Network — $300M Pre-IPO Raise
Active · Pre-IPO Raise
Park Medi World
Hospital Network
North India · 13 Hospitals · 3,000 Beds
Capital Raise$300M · 20% Equity · $1.5B Valuation

Second-largest private hospital chain in North India · largest in Haryana. 13 NABH-accredited hospitals, 3,000 beds (805 ICU), 891 doctors, 1,912 nurses. DRHP filed with SEBI Mar-2025. Raise funds 1,350-bed pipeline to 4,350 beds by Mar-2028. Industry-leading 25% EBITDA margin · 10× FY24 revenue valuation — a 50–67% discount to 20–30× sector comparables. Projected 2–3× MOIC post-IPO re-rating.

Disclaimer · Investment Materials
Confidentiality & Forward-Looking Statements
This document summarises publicly-releasable project information and does not constitute an offer or solicitation of an offer to buy or sell securities. Forward-looking statements involve risks and uncertainties; actual results may differ materially. Past performance is not indicative of future results.

Confidential sponsor, contact, and financial details are available to authorized investors via the gated Bio & Contact and Business Plan materials.